scholarly journals Superior hypogastric plexus

2021 ◽  
Author(s):  
Tristan Skalina
Keyword(s):  
Hypogastric Plexus ◽  
Superior Hypogastric Plexus

Case report: Tenesmus and the role of superior hypogastric plexus blocks

2018 ◽  
Vol 33 (3) ◽  
pp. 392-395
Author(s):  
Weiyang Christopher Liu ◽  
David Flamer
Keyword(s):  
Case Report ◽  
Hypogastric Plexus ◽  
Superior Hypogastric Plexus

scholarly journals Computed Tomography-Guided Superior Hypogastric Plexus Block for Secondary Dysmenorrhea in Perimenopausal Women

2018 ◽  
Vol 24 ◽  
pp. 5132-5138 ◽  
Author(s):  
Xiaomin Yang ◽  
Jihong You ◽  
Suping Tao ◽  
Xin Zheng ◽  
Keyue Xie ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Hypogastric Plexus ◽  
Perimenopausal Women ◽  
Superior Hypogastric Plexus ◽  
Secondary Dysmenorrhea ◽  
Plexus Block

Superior Hypogastric Plexus Block to Reduce Pain After Laparoscopic Hysterectomy

2021 ◽  
Vol 137 (4) ◽  
pp. 648-656
Author(s):  
Nisse V. Clark ◽  
Kristin Moore ◽  
Parmida Maghsoudlou ◽  
Alexandra North ◽  
Mobolaji O. Ajao ◽  
...  
Keyword(s):  
Laparoscopic Hysterectomy ◽  
Hypogastric Plexus ◽  
Superior Hypogastric Plexus ◽  
Plexus Block

Efficacy of Superior Hypogastric Plexus Neurolysis for the Treatment of Cancer-Related Pelvic Pain

Pain Medicine ◽  
2019 ◽  
Vol 21 (6) ◽  
pp. 1255-1262 ◽  
Author(s):  
Saiyun Hou ◽  
Diane Novy ◽  
Francis Felice ◽  
Dhanalakshmi Koyyalagunta
Keyword(s):  
Pelvic Pain ◽  
Rating Scale ◽  
Symptom Burden ◽  
Assessment System ◽  
Cancer Center ◽  
Safe Procedure ◽  
Pelvic Malignancies ◽  
Hypogastric Plexus ◽  
Superior Hypogastric Plexus

Abstract Objective Cancer-related abdominal and pelvic pain syndromes can be debilitating and difficult to treat. The objective of this study was to evaluate the efficacy of superior hypogastric plexus blockade or neurolysis (SHPN) for the treatment of cancer-related pelvic pain. Design Retrospective study. Setting MD Anderson Cancer Center, Houston, Texas. Methods We enrolled 46 patients with cancer-related pelvic pain who underwent SHPN. A numeric rating scale (NRS) was used for pain intensity, and symptom burden was evaluated using the Edmonton Symptom Assessment System at baseline, visit 1 (within one month), and visit 2 (within one to six months). Results Forty-six patients who received SHPN showed a significant reduction in pain score from 6.9 to 5.6 at visit 1 (P = 0.01). Thirty of the 46 patients continued to complete visit 2 follow-up, and the NRS score was consistently lower at 4.5 at visit 2 (P < 0.0001), with anxiety and appetite improved significantly. There was no significant change in the morphine equivalent dose at visits 1 and 2. The efficacy of the block was not influenced by patients’ age, gender, type of cancer, cancer stage, regimen of chemotherapy and/or radiation therapy, diagnostic block, approach or laterality of procedure, or type or amount of neurolytic agent. Nonsmokers with high baseline pain scores were more likely to have improved treatment outcomes from SHPN at short-term follow-up. Adverse effects with SHPN were mild and well tolerated. Conclusions SHPN was an effective and relatively safe procedure for pain associated with pelvic malignancies. There is a need for larger prospective trials.

Sign in / Sign up

Export Citation Format

Share Document